Cambridge Advisors’s Illumina ILMN Stock Holding History

Cambridge Advisors’s Portfolio ILMN Stock Details ILMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,054	Closed	-$280K	–	145
2020 Q1	$280K	Buy	+1,054	New	+$295K	0.1%	112

Other funds holding ILMN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Cambridge Advisors's ILMN Position: Q2 2020 in Review

Cambridge Advisors sold out of Illumina (ILMN) in Q2 2020, closing a stake of 1,054 shares — an estimated $280K sold.

Cambridge Advisors first reported a position in ILMN in Q1 2020 and held it in 1 quarter. The position peaked at $280K in Q1 2020. 891 funds tracked by Wall St. Rank hold ILMN as of Q2 2020.

Cambridge Advisors reported no remaining Illumina position as of Q2 2020 after selling out during the quarter.
Cambridge Advisors sold 1,054 Illumina shares in Q2 2020, an estimated $280K.
Cambridge Advisors first reported a position in Illumina in Q1 2020 and held it in 1 quarter.
Cambridge Advisors's Illumina position peaked at $280K in Q1 2020.
891 funds tracked by Wall St. Rank held Illumina as of Q2 2020.

Based on Cambridge Advisors's 13F filing for Q2 2020, filed 17 Jul 2020.